[{"Assets_0_Q2_USD":"1057581000.0","CIK":"1706431","CommonStockSharesIssued_0_Q2_shares":"130479975.0","CommonStockSharesOutstanding_0_Q2_shares":"130479975.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.48","EarningsPerShareBasic_2_Q2_USD":"-0.83","EarningsPerShareDiluted_1_Q2_USD":"0.46","EarningsPerShareDiluted_2_Q2_USD":"-0.83","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"50529000.0","NetIncomeLoss_1_Q2_USD":"61813000.0","NetIncomeLoss_2_Q2_USD":"-107098000.0","OfficialName":"Vir Biotechnology Inc. Common Stock","ProfitLoss_2_Q2_USD":"-107098000.0","RevenuesConverted_1_Q2_USD":"177068000.0","RevenuesConverted_2_Q2_USD":"179052000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"737325000.0","Ticker":"VIR","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"133789977.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"128938851.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"130121943.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"128938851.0","filed":"20210805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20210630","qtrs":"1","uom":"USD"}]